Fate Therapeutics

Top five biopharma companies hiring in San Diego
BioSpace
Thu, 04/11/24 - 10:55 am
San Diego
biotech
hirings
Avidity Biosciences
Element Biosciences
AnaptysBio
Fate Therapeutics
Takeda
Biotech layoffs gather pace as industry downturn persists
BioPharma Dive
Tue, 04/11/23 - 07:18 pm
layoffs
biotech
Amgen
Pfizer
Roche
Jounce Therapeutics
Fate Therapeutics
Molecular Templates
Sorrento Therapeutics
Fate hits reset as J&J cell therapy deal collapses, slashing pipeline and head count to stretch cash
Fierce Biotech
Fri, 01/6/23 - 09:43 am
Fate Therapeutics
JNJ
cell therapy
layoffs
Biotech’s key upcoming clinical results
EP Vantage
Tue, 12/20/22 - 10:27 am
clinical trials
Acadia Pharmaceuticals
Argenx
Arrowhead Pharmaceuticals
Biomarin
BioNTech
Daiichi Sankyo
Day One
EQRx
Fate Therapeutics
FibroGen
Gilead Sciences
Idorsia
Immunogen
Intellia Therapeutics
Karuna Therapeutics
Moderna Therapeutics
Regeneron
Roche
Travere Therapeutics
Vaxcyte
Nkarta: at least as good as Fate, at a tenth of the price
EP Vantage
Mon, 04/25/22 - 10:13 am
Nkarta
Fate Therapeutics
natural killer cells
Fate delivers, up to a point
EP Vantage
Fri, 08/20/21 - 12:36 pm
Fate Therapeutics
natural killer cells
CAR-NK
FT596
Red-Hot Biotechs to Take Spotlight at Blood Disorder Meeting
Yahoo/Bloomberg
Fri, 12/4/20 - 11:09 am
ASH2020
Trillium Therapeutics
CRISPR Therapeutics
Fate Therapeutics
Vertex Pharmaceuticals
J&J inks Fate deal to move into allogeneic CAR therapies
Fierce Biotech
Fri, 04/3/20 - 12:29 pm
JNJ
Fate Therapeutics
CAR NK
CAR-T
cell therapies
drug development
Off-the-shelf cell therapy for cancer? Fate Therapeutics to make its case at ASH
Fierce Biotech
Sat, 12/1/18 - 11:51 am
Fate Therapeutics
FDA
FT500
solid tumors
Fate Therapeutics Unveils Preclinical Findings of Newly-Identified Small Molecule Modulator Combination for Ex Vivo Programming of Mobilized Peripheral Blood
Yahoo/Globe NewsWire
Sun, 12/7/14 - 09:01 am
Fate Therapeutics
hematologic cancers
Fate Therapeutics' Prohema in Phase II Study
Yahoo/Zacks.com
Thu, 03/13/14 - 11:39 am
Prohema
Fate Therapeutics
stem cells
[video]Biotech IPOs With Big Partners
TheStreet.com
Thu, 09/19/13 - 03:13 am
biotech
IPOs
Celgene
Amgen
Bind Therapeutics
Acceleron
Fate Therapeutics
Biotechs keep the cash pumping (for now) with more IPOs and ATMs
Fierce Biotech
Tue, 09/17/13 - 10:02 am
IPOs
Fate Therapeutics
biotech
ATMs
Matthew Herper And Robert Langreth On The Pharmaceutical Industry: in 2010, a major drug company will break up
Forbes
Mon, 12/28/09 - 05:01 am
JNJ
Medtronic
Pfizer
Vytorin
Boehringer Ingelheim
Elan
Eli Lilly
Fate Therapeutics
Gilead Sciences
Merck
Schering Plough
Wyeth
Fate Therapeutics Seals $30 M Series B, Gets Corporate Venture On Board
InVivo
Mon, 11/16/09 - 10:34 am
Fate Therapeutics
Genzyme
Astellas